Lock in 53.57% Gains in Pharmaceutical Options in Just Five Days

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

It was a down week for U.S. markets, as the Dow Jones fell 0.87% and the S&P 500 tumbled 1.10%. The NASDAQ held up the best and was down only 0.33%. The MCSI Emerging Markets Index endured a massive drop, plummeting 4.49%.

There were not big gainers in your Bull Market Alert portfolio this week, as only China’s Vipshop Holdings Limited (VIPS) was able to eke out a 0.85% gain. Two positions, the iShares MSCI BRIC ETF (BKF) and Vipshop Holdings Limited (VIPS), fell below their 50-day moving averages and moved to a HOLD.

Thanks to the quirkiness of option pricing, Gilead options actually rose last week even as the stock closed slightly lower. Sell half of your Gilead November $100 call options (GILD141122C00100000) at market today to lock in 53.57% gains.

On the downside, close your position in your Visa $215 call option (V140920C00215000), which expires this Friday, at a loss. Although Visa’s stock itself is up 7.33% since my initial recommendation, it has been a bumpy rise and the option never got any traction.

Markets are starting the week in a grumpy mood. Asian stocks slid to a five-week low this morning as data out of China showed that factory output there grew at the weakest pace in nearly six years.

Throw in the uncertainties surrounding the Scottish referendum and the Fed Open Market Committee meeting this week, and you can see why investors are particularly cautious about taking on new risk.

Finally, I’ve highlighted the weak September seasonality in the past. As you can see from the chart below, the coming seven trading days have been historically some of the worst trading days of the year.

20140913 sentimentrader bma

Source: SentimenTrader.com

On average, all but one of the next seven days has been a down day in the market over the past 30 years.

Exclusive  A New Algorithm Pick, Booking Triple-Digit Percentage Gains and Making a Pair of Option Trades

Now you see why this is not a time you want to place new bets in the market.

I’ll be back with a new Bull Market Alert recommendation next week.

Portfolio Update

The Bank of Ireland (IRE) gave back 2.92% last week. Although a down week for The Bank of Ireland, IRE did take a convincing bounce higher midweek from its recent strong breach of the 200-day moving average (MA). Watch this price action closely as a definitive move higher in the short term could be an indicator for a longer-term trend. IRE is a BUY.

iShares MSCI BRIC ETF (BKF) fell 5.07%. Emerging markets had a remarkably tough time last week, and the BRICs fell in tandem. The rest of the world believes the United States and a coalition of allies are “going to war” against radical Islamic forces in the Middle East. But listening to President Barack Obama and his staff last week, the United States is simply extending its “anti-terrorist activities.” However you put it, BKF fell below its 50-day MA last Friday to become a HOLD.

Vipshop Holdings Limited (VIPS) gained 0.85% last week. One of the more impressive data points in the VIPS story is its record of beating earnings expectations over the last five quarterly reports. This trend has no signs of abating in the near future. Although VIPS had a small gain for the week, due to a rising 50-day MA, VIPS actually fell slightly below this line to become a HOLD.

United Rentals, Inc. (URI) gave back 1.61% over the past five trading days. URI received some big news last week as Standard & Poor’s announced that this stock symbol would become a member of the S&P 500 this Friday. URI will leave its place in the S&P MidCap 400 index to go join the big leagues. URI is a BUY.

Exclusive  The Global Bull Bets on China and the Sun

Trinity Industries (TRN) fell 2.27%. TRN declared a quarterly dividend of $0.10 per share last week. Remarkably, this will be Trinity’s 202nd consecutively paid dividend. This dividend is payable on Oct. 31 to stockholders of record as of Oct. 15. TRN is a BUY.

Gilead Sciences Inc. (GILD) dipped 1.61% for its opening week in your portfolio. Not only is Gilead’s stock symbol currently “on sale,” courtesy of a recent news-driven dip, but, as a member of the biotech sector, it benefits from the strong rebound this sector has been experiencing for many months now. GILD is a BUY.

Nicholas Vardy

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE


img
previous article

World and corporate leaders should look for alternative business partners to minimize the fallout from trade barriers that Russia’s President Vladimir Putin may erect against countries that impose trade sanctions against his nation in response to his sending Russian fighters into neighboring Ukraine.

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE